吉林敖东集团商业模式改进研究

发布时间：2018-04-30 19:08

本文选题：商业模式 + 医药企业　；参考：《吉林财经大学》2017年硕士论文

【摘要】：商业模式作为管理学的研究对象之一,它在现代企业管理中具有非常重要的地位,同时它也是提升企业竞争力的关键。医药行业作为民生的重要组成部分,由于人们的健康问题被持续关注,所以本文认为,医药行业的商业模式就变得很有研究价值。建国以来,各个地区的医药行业取得了迅速发展,当今经济社会出现了前所未有的新常态的发展趋势,那么对于市场来讲,一个新的论题就油然而生,市场该如何发展出一个新的商业模式来面对当下的新常态呢?本文的研究工作主要是在我国现有经济新常态的背景下,针对吉林敖东集团现有的发展情况,有针对性的为其商业模式的创新提出改进建议。本文通过查阅相关资料,在文献研究的基础上,分别对企业竞争优势理论、商业模式理论进行了进一步的梳理,提出了利用“三维度”商业模式理论分析吉林敖东现有的商业模式,即分别从价值链、产业链和资金链等三个方面进行分析,从而发现吉林敖东药业集团现有商业模式中存在的问题,并针对吉林敖东集团现有的问题分别提出了改进意见,即:基于“互联网+”价值网络的价值链拓展、产业链的完善与发展和资金链的优化设计。通过上述研究,初步提出了以价值链作为医药行业的商业模式核心进行敖东集团商业模式重构的理念,以期待能够增加东北地区医药企业的价值贡献率,增加中药产业为敖东提供更高的利润贡献,但由于商业模式创新不是一个简单的过程,目前的研究还有待提高,所以本文的最后进行了总结并提出了希望。
[Abstract]:As one of the research objects of management, business model plays a very important role in modern enterprise management, and it is also the key to enhance the competitiveness of enterprises. As an important part of people's livelihood, the medical industry has been paid more and more attention to, so this paper thinks that the business model of pharmaceutical industry has become very valuable. Since the founding of the people's Republic of China, the pharmaceutical industry in various regions has made rapid development, and today's economic and social development has witnessed an unprecedented new normal trend. Well, for the market, a new topic arises spontaneously. How can the market develop a new business model to face the new normal? The research work of this paper is mainly in the background of the new normal of our country's current economy, aiming at the existing development situation of Jilin Aodong Group, it puts forward some suggestions for the innovation of its business model. Based on the literature research, this paper further combs the theory of enterprise competitive advantage and the theory of business model. This paper puts forward to use the theory of "three dimensions" to analyze the existing business models in Aodong, Jilin Province, from three aspects, namely, value chain, industry chain and capital chain. The problems in the existing business model of Jilin Aodong Pharmaceutical Group are found, and the improvement suggestions are put forward respectively, that is, the value chain expansion based on the value network of "Internet". The perfection and development of the industrial chain and the optimization design of the capital chain. Through the above research, the paper puts forward the idea of reconstructing the business model of Aodong Group with the value chain as the core of the business model of the pharmaceutical industry, in order to increase the value contribution rate of the pharmaceutical enterprises in Northeast China. Increasing the traditional Chinese medicine industry for Aodong to provide a higher profit contribution, but because the business model innovation is not a simple process, the current research has yet to be improved, so this paper summarized and put forward the hope.
【学位授予单位】：吉林财经大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F426.72

【参考文献】